NSC 42834
- Product Name
- NSC 42834
- CAS No.
- 195371-52-9
- Chemical Name
- NSC 42834
- Synonyms
- NSC 42834;1-Butanone;NSC 42834,Z3;Z3(NSC 42834);JAK2 Inhibitor V;NSC 42834,Z3, >95%;JAK2 Inhibitor V, Z3;JAK2 Inhibitor V Z3|||Z3;JAK2 Inhibitor V, Z3, >=98%;NSC 42834 (JAK2 INHIBITOR V)
- CBNumber
- CB62645144
- Molecular Formula
- C23H24N2O
- Formula Weight
- 344.45
- MOL File
- 195371-52-9.mol
NSC 42834 Property
- Boiling point:
- 520.4±50.0 °C(Predicted)
- Density
- 1.106±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml
- form
- Powder
- pka
- 5.90±0.12(Predicted)
- color
- Colorless to light yellow
N-Bromosuccinimide Price
- Product number
- 420141
- Product name
- JAK2 Inhibitor V, Z3 - CAS 195371-52-9 - Calbiochem
- Packaging
- 10MG
- Price
- $154
- Updated
- 2023/01/07
- Product number
- 17684
- Product name
- JAK2 Inhibitor V
- Purity
- ≥95%
- Packaging
- 1mg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 17684
- Product name
- JAK2 Inhibitor V
- Purity
- ≥95%
- Packaging
- 5mg
- Price
- $78
- Updated
- 2024/03/01
- Product number
- 17684
- Product name
- JAK2 Inhibitor V
- Purity
- ≥95%
- Packaging
- 10mg
- Price
- $122
- Updated
- 2024/03/01
- Product number
- 17684
- Product name
- JAK2 Inhibitor V
- Purity
- ≥95%
- Packaging
- 25mg
- Price
- $267
- Updated
- 2024/03/01
NSC 42834 Chemical Properties,Usage,Production
Uses
NSC 42834 (JAK2 Inhibitor V), a novel specific inhibitor of Jak2, inhibits Jak2-V617F and Jak2-WT autophosphorylation in a dose-dependent manner but was not cytotoxic to cells at concentrations that inhibited kinase activity.
IC 50
JAK2-WT: 15 μM (IC50); JAK2-V617F: 28 μM (IC50)
References
[1] Jacqueline Sayyah, Andrew Magis, David A. Ostrov, et al. Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth . Mol Cancer Ther 2008;7(8):2308-18.
[2] Jacqueline Sayyah, Peter P. Sayeski. Jak2 inhibitors: Rationale and role as therapeutic agents in hematologic malignancies. Current Oncology Reports. 2009, 11(2): 117-124.
[3] Ehab Atallah , Srdan Verstovsek . Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms. Expert Review of Anticancer Therapy. 2009,9 (5):663-670.
NSC 42834 Preparation Products And Raw materials
Raw materials
Preparation Products
NSC 42834 Suppliers
- Tel
- --
- Fax
- --
- sales@ajchem.in
- Country
- India
- ProdList
- 6100
- Advantage
- 58
View Lastest Price from NSC 42834 manufacturers
- Product
- 2-METHYL-1-PHENYL-4-(PYRIDIN-2-YL)-2-(2-(PYRIDIN-2-YL)ETHYL)BUTAN-1-ONE 195371-52-9
- Price
- US $1.00/ASSAYS
- Min. Order
- 1ASSAYS
- Purity
- 98%
- Supply Ability
- 10kg
- Release date
- 2019-09-04